OCT News and Research

RSS

AAO highlights dangers of wearing illegal costume contact lenses

Spooky contact lenses can complete your Halloween costume. But beware of the dangers of illegal costume contact lenses lurking on store shelves and invading online retailers.

25 Oct 2019

Researchers find antibody that may protect against wide range of lethal influenza viruses

A nationwide team of researchers has found an antibody that protects mice against a wide range of potentially lethal influenza viruses, advancing efforts to design of a universal vaccine that could either treat or protect people against all strains of the virus.

25 Oct 2019

AAOMPT opposes use of 'degenerative disc disease' as diagnostic term for neck, back pain

The American Academy of Orthopaedic Manual Physical Therapists has released a position statement opposing "degenerative disc disease" as a diagnostic term for the cause of neck and back pain.

25 Oct 2019

First-line antihypertensives may not be most effective, study shows

Thiazide diuretics demonstrate better effectiveness and cause fewer side effects than ACE inhibitors as first-line antihypertensive drugs, according to a report published Oct. 24 in The Lancet.

25 Oct 2019

Study pinpoints cell types linked to age-related macular degeneration

Age-related macular degeneration is one of the leading causes of blindness in the elderly, affecting more than 2 million people in the United States and leading to progressive loss of central vision.

25 Oct 2019

Novel amyloid protein that induces amyloidosis discovered

A collaboration led by scientists at Tokyo University of Agriculture and Technology, Japan, has discovered a novel amyloid protein that induces amyloidosis in rats.

25 Oct 2019

Most popular first-line treatment for hypertension may be less effective than alternative drugs

A new multinational study shows that the most popular first-line treatment for hypertension is less effective and has more side effects than an alternative that's prescribed much less often.

25 Oct 2019

Study finds heightened risk of adverse financial outcomes prior to Alzheimer's diagnosis

Prior to an Alzheimer's diagnosis, a person in the early stages of the disease faces a heightened risk of adverse financial outcomes - a likely consequence of compromised decision making when managing money, in addition to exploitation and fraud by others.

25 Oct 2019

Flu antibody could be a key to better treatments for severe flu disease

Researchers have found an antibody that protects mice against a wide range of lethal influenza viruses, according to a study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.

24 Oct 2019

Parents' behavior can have substantial impact on developing oxytocin systems in babies

Oxytocin is an extremely important hormone, involved in social interaction and bonding in mammals, including humans.

24 Oct 2019

Gene linked to schizophrenia likely confers risk for illness

Researchers have discovered in mice how one of the few genes definitively linked to schizophrenia, called SETD1A, likely confers risk for the illness. Mice genetically engineered to lack a functioning version of the enzyme-coding gene showed abnormalities in working memory, mimicking those commonly seen in schizophrenia patients.

24 Oct 2019

Direct current stimulation device aids in spinal fusion procedure

Spine surgeons in the U.S. perform more than 400,000 spinal fusions each year as a way to ease back pain and prevent vertebrae in the spine from wiggling around and doing more damage.

24 Oct 2019

As vaping devices evolve, new potential hazards scrutinized

The smokeless tobacco industry that began with low-voltage cigarette look-alikes has evolved to include customizable, high-wattage machines capable of generating enormous clouds of vapor - and potentially toxic substances.

24 Oct 2019

Cooperative research center at LLNL aims to develop vaccines for chlamydia

A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory.

24 Oct 2019

Molecular processes underlying communication between gut microbes and brain cells revealed

New cellular and molecular processes underlying communication between gut microbes and brain cells have been described for the first time by scientists at Weill Cornell Medicine and Cornell's Ithaca campus.

23 Oct 2019

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Neuroscientists at Georgetown University Medical Center say they have developed and tested an agent that reduces the buildup of toxic proteins in animal models of both Parkinson's and Alzheimer's diseases, and improves cognitive and motor behavior.

23 Oct 2019

Cleveland Clinic announces Top 10 Medical Innovations for 2020

A dual-acting osteoporosis drug. Minimally invasive mitral valve surgery. New treatment for peanut allergies. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.

23 Oct 2019

MIT neuroscientists find a way to reverse noise hypersensitivity in mice

People with autism often experience hypersensitivity to noise and other sensory input. MIT neuroscientists have now identified two brain circuits that help tune out distracting sensory information, and they have found a way to reverse noise hypersensitivity in mice by boosting the activity of those circuits.

23 Oct 2019

Weight gain and high blood pressure in college football players linked to heart problems

Weight gain and high blood pressure in college football players leads to adverse changes in cardiac structure and function, indicating monitoring and early intervention is needed for this young and otherwise healthy athletic population, according to a new study by Emory University researchers.

23 Oct 2019

New study indicates a way to improve cancer immunotherapy

Cancer immunotherapy drugs trigger the body's immune system to attack tumors and have revolutionized the treatment of certain cancers, such as lymphoma, lung cancer and melanoma. Yet, while some patients respond well to the drugs, others don't respond at all. Cancer immunologists want to change that.

23 Oct 2019

OCT News and Research

AAO highlights dangers of wearing illegal costume contact lenses

Researchers find antibody that may protect against wide range of lethal influenza viruses

AAOMPT opposes use of 'degenerative disc disease' as diagnostic term for neck, back pain

First-line antihypertensives may not be most effective, study shows

Study pinpoints cell types linked to age-related macular degeneration

Novel amyloid protein that induces amyloidosis discovered

Most popular first-line treatment for hypertension may be less effective than alternative drugs

Study finds heightened risk of adverse financial outcomes prior to Alzheimer's diagnosis

Flu antibody could be a key to better treatments for severe flu disease

Parents' behavior can have substantial impact on developing oxytocin systems in babies

Gene linked to schizophrenia likely confers risk for illness

Direct current stimulation device aids in spinal fusion procedure

As vaping devices evolve, new potential hazards scrutinized

Cooperative research center at LLNL aims to develop vaccines for chlamydia

Molecular processes underlying communication between gut microbes and brain cells revealed

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Cleveland Clinic announces Top 10 Medical Innovations for 2020

MIT neuroscientists find a way to reverse noise hypersensitivity in mice

Weight gain and high blood pressure in college football players linked to heart problems

New study indicates a way to improve cancer immunotherapy

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News